25-Hydroxyvitamin D Is Associated with Islet Homeostasis in Type-2 Diabetic Patients with Abdominal Obesity

Overview

Journal Curr Med Sci

Specialty General Medicine

Date 2023 Sep 11

PMID 37697161

Authors

Qing Li

Wen Zhang

Bing Han

Yu-Ying Wang

Heng Wan

Min Zhang

Ning-Jian Wang

Ying-Li Lu

Affiliations

Soon will be listed here.

Abstract

Objective: Islet α cells input is essential for insulin secretion from β cells. The present study aims to investigate the association between 25-hydroxyvitamin D [25(OH)D] and islet function homeostasis in type-2 diabetes (T2D) patients.

Methods: A total of 4670 T2D patients from seven communities in Shanghai, China were enrolled. The anthropometric indices, biochemical parameters, serum 25(OH)D, and islet function [including C-peptide (C-p) and glucagon] were measured.

Results: The fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), glucagon, and C-p levels exhibited a significantly decreasing trend in T2D patients as the 25(OH)D levels increased. Next, the population was divided into two groups: abdominal obesity and non-abdominal obesity groups. After adjustment, the 25(OH)D level was found to be associated with HbA1c, glucagon, and homeostasis model assessment of β (HOMA-β) in the non-abdominal obesity group. There was a significant relationship between 25(OH)D and HbA1c, glucagon, HOMA-IR, baseline insulin or C-p in the abdominal obesity group. In the abdominal obesity group, the ordinary least squares (OLS) regression and quantile regression revealed that 25(OH) D was obviously associated with glucagon and fasting C-p levels. In the abdominal obesity group, the moderate analysis revealed a significant interaction effect of 25(OH)D and glucagon on C-p (P=0.0124). Furthermore, the conditional indirect effect of 25(OH)D on the glucagon/C-p ratio was significantly lower at 1 standard deviation (SD) below the mean (P=0.0002), and lower at the mean of the course of diabetes (P=0.0007).

Conclusion: 25(OH)D was found to be negatively correlated to glucagon and C-p in T2D patients with abdominal obesity. The 25(OH)D influenced C-p in part by influencing glucagon. The effect of 25(OH)D on the glucagon/C-p ratio in T2D patients with abdominal obesity, in terms of islet homeostasis, is influenced by the course of diabetes.

References

Svendsen B, Larsen O, Gabe M, Christiansen C, Rosenkilde M, Drucker D . Insulin Secretion Depends on Intra-islet Glucagon Signaling. Cell Rep. 2018; 25(5):1127-1134.e2. DOI: 10.1016/j.celrep.2018.10.018. View

Ackermann A, Wang Z, Schug J, Naji A, Kaestner K . Integration of ATAC-seq and RNA-seq identifies human alpha cell and beta cell signature genes. Mol Metab. 2016; 5(3):233-244. PMC: 4770267. DOI: 10.1016/j.molmet.2016.01.002. View

Capozzi M, Wait J, Koech J, Gordon A, Coch R, Svendsen B . Glucagon lowers glycemia when β-cells are active. JCI Insight. 2019; 5. PMC: 6777806. DOI: 10.1172/jci.insight.129954. View

Holick M, Chen T . Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008; 87(4):1080S-6S. DOI: 10.1093/ajcn/87.4.1080S. View

Mathieu C, Gysemans C, Giulietti A, Bouillon R . Vitamin D and diabetes. Diabetologia. 2005; 48(7):1247-57. DOI: 10.1007/s00125-005-1802-7. View

Sandler S, Buschard K, Bendtzen K . Effects of 1,25-dihydroxyvitamin D3 and the analogues MC903 and KH1060 on interleukin-1 beta-induced inhibition of rat pancreatic islet beta-cell function in vitro. Immunol Lett. 1994; 41(1):73-7. DOI: 10.1016/0165-2478(94)90059-0. View

Norman A, Frankel J, Heldt A, GRODSKY G . Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980; 209(4458):823-5. DOI: 10.1126/science.6250216. View

Santos R, Vianna L . Effect of cholecalciferol supplementation on blood glucose in an experimental model of type 2 diabetes mellitus in spontaneously hypertensive rats and Wistar rats. Clin Chim Acta. 2005; 358(1-2):146-50. DOI: 10.1016/j.cccn.2005.02.020. View

Orwoll E, Riddle M, Prince M . Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr. 1994; 59(5):1083-7. DOI: 10.1093/ajcn/59.5.1083. View

10.

Elseweidy M, Amin R, Atteia H, Ali M . Vitamin D3 intake as regulator of insulin degrading enzyme and insulin receptor phosphorylation in diabetic rats. Biomed Pharmacother. 2016; 85:155-159. DOI: 10.1016/j.biopha.2016.11.116. View

11.

Viloria K, Hewison M, Hodson D . Vitamin D binding protein/GC-globulin: a novel regulator of alpha cell function and glucagon secretion. J Physiol. 2021; 600(5):1119-1133. DOI: 10.1113/JP280890. View

12.

Wan H, Wang Y, Xiang Q, Fang S, Chen Y, Chen C . Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020; 19(1):118. PMC: 7395356. DOI: 10.1186/s12933-020-01095-4. View

13.

Wang Y, Weng P, Wan H, Zhang W, Chen C, Chen Y . Economic Status Moderates the Association Between Early-Life Famine Exposure and Hyperuricemia in Adulthood. J Clin Endocrinol Metab. 2020; 105(11). DOI: 10.1210/clinem/dgaa523. View

14.

Chen Y, Cheng J, Chen Y, Wang N, Xia F, Chen C . Association between serum vitamin D and uric acid in the eastern Chinese population: a population-based cross-sectional study. BMC Endocr Disord. 2020; 20(1):79. PMC: 7268462. DOI: 10.1186/s12902-020-00560-1. View

15.

Li Q, Lu M, Wang N, Chen Y, Chen Y, Han B . Relationship between Free Thyroxine and Islet Beta-cell Function in Euthyroid Subjects. Curr Med Sci. 2020; 40(1):69-77. DOI: 10.1007/s11596-020-2148-6. View

16.

Xu Y, Wang L, He J, Bi Y, Li M, Wang T . Prevalence and control of diabetes in Chinese adults. JAMA. 2013; 310(9):948-59. DOI: 10.1001/jama.2013.168118. View

17.

Brissova M, Fowler M, Nicholson W, Chu A, Hirshberg B, Harlan D . Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem. 2005; 53(9):1087-97. DOI: 10.1369/jhc.5C6684.2005. View

18.

Zhao H, Zheng C, Zhang M, Chen S . The relationship between vitamin D status and islet function in patients with type 2 diabetes mellitus. BMC Endocr Disord. 2021; 21(1):203. PMC: 8522231. DOI: 10.1186/s12902-021-00862-y. View

19.

Heaney R . Toward a physiological referent for the vitamin D requirement. J Endocrinol Invest. 2014; 37(11):1127-30. DOI: 10.1007/s40618-014-0190-6. View

20.

Ekwaru J, Zwicker J, Holick M, Giovannucci E, Veugelers P . The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One. 2014; 9(11):e111265. PMC: 4220998. DOI: 10.1371/journal.pone.0111265. View